JSLGX
Price
$14.40
Change
-$0.02 (-0.14%)
Updated
May 23 closing price
Net Assets
8.24B
JULGX
Price
$14.33
Change
-$0.03 (-0.21%)
Updated
May 23 closing price
Net Assets
8.24B
Interact to see
Advertisement

JSLGX vs JULGX

Header iconJSLGX vs JULGX Comparison
Open Charts JSLGX vs JULGXBanner chart's image
JHancock Multimanager Lifestyle Gr R4
Price$14.40
Change-$0.02 (-0.14%)
VolumeN/A
Net Assets8.24B
JHancock Multimanager Lifestyle Gr R6
Price$14.33
Change-$0.03 (-0.21%)
VolumeN/A
Net Assets8.24B
JSLGX vs JULGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSLGX vs. JULGX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSLGX is a Hold and JULGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JSLGX (8.24B) and JULGX (8.24B) have equal amount of cash in the bank . JULGX pays higher dividends than JSLGX: JULGX (2.42) vs JSLGX (2.16). JSLGX was incepted earlier than JULGX: JSLGX (20 years) vs JULGX (14 years). JSLGX (1.22) is less costly to investors than JULGX (0.97). JSLGX (13.00) and JULGX (13.00) have comparable annual turnover. JSLGX has a lower initial minimum investment than JULGX: JSLGX (0) vs JULGX (1000000). JULGX (6.22) and JSLGX (5.94) have marching annual gain over last year. JULGX return over 5 years is better than : 21.84 vs. JSLGX (20.74).
JSLGXJULGXJSLGX / JULGX
Total Expense Ratio1.220.97126%
Annual Report Gross Expense Ratio1.220.97126%
Fund Existence20 years14 years-
Gain YTD2.3422.42797%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.24B8.24B100%
Annual Yield % from dividends2.162.4289%
Returns for 1 year5.946.2295%
Returns for 3 years7.768.2994%
Returns for 5 years20.7421.8495%
Returns for 10 years-2.82-1.33212%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTMTX21.17N/A
N/A
Goldman Sachs Small/Mid Cap Growth Inv
NMVLX11.55N/A
N/A
Nuance Mid Cap Value Institutional
BHCHX17.50N/A
N/A
Baron Health Care Instl
BTEKX72.17N/A
N/A
BlackRock Technology Opportunities K
GEMLX12.37N/A
N/A
Goldman Sachs Emerging Mkts Eq ex. Chn C